Articles published by Alchemab Therapeutics

Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline

Today 3:14 EDT

From Alchemab Therapeutics

Via Business Wire

Alchemab Therapeutics Announces Largest Ever Life Sciences Investment From British Business Bank to Advance AI-Enabled Clinical Pipeline of Next Generation Human-Derived Antibodies

July 09, 2026

From Alchemab Therapeutics

Via Business Wire

Ulrich Wendt joins UK biotech Alchemab Therapeutics as Chief Business Officer to expand biopharma partnerships

March 17, 2026

From Alchemab Therapeutics

Via Business Wire

Alchemab Appoints Young T. Kwon as Chief Executive Officer

May 26, 2022

From Alchemab Therapeutics

Via Business Wire

Alchemab Announces Publication of AntiBERTa, an Antibody-Specific Machine Learning Model with Multiple Applications

May 19, 2022

From Alchemab Therapeutics

Via Business Wire

Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery

March 22, 2022

From Alchemab Therapeutics

Via Business Wire

Alchemab Therapeutics Appoints Young T. Kwon, PhD as Chief Financial and Operating Officer

November 15, 2021

From Alchemab Therapeutics

Via Business Wire

Alchemab raises £60M ($82M) in Series A financing to advance novel platform for identifying disease-modifying antibody therapeutics

April 15, 2021

From Alchemab Therapeutics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.